KDKoji Daito

Koji Daito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Koji Daito has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Junichiro Kawamura

    Department of Surgery, Faculty of Medicine, Kindai University, Osaka 590-0197, Japan

    3 shared publications
  • Kazuki Ueda

    Division of Endoscopic and Colorectal Surgery, Department of Surgery, Kindai University Faculty of Medicine , Osaka

    3 shared publications
  • Kiyotaka Okuno

    Department of Surgery, Kindai University Faculty of Medicine, 377-2 Ohno higashi, Osakasayama, Osaka, 589-8511, Japan

    2 shared publications
  • Tadao Tokoro

    Division of Endoscopic and Colorectal Surgery Department of Surgery Kindai University Faculty of Medicine Osaka sayama 589-8511 Osaka Japan

    2 shared publications
  • Tadao Tokoro

    Department of Surgery, Kinki University, Faculty of Medicine, Osaka, Japan

    2 shared publications
  • Yasumasa Yoshioka

    Division of Endoscopic and Colorectal Surgery Department of Surgery Kindai University Faculty of Medicine Osaka sayama 589-8511 Osaka Japan

    2 shared publications

Latest Publications

  • Open Access

    Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study

    by Koichi Komatsu, Takahide Shinagawa, Motoi Uchino, Hiroki Ikeuchi, Koji Okabayashi, Shiro Oka, Kitaro Futami, Michio Itabashi, Kazuhiro Watanabe, Masatsune Shibutani, et al.

    Background/Aims: Ulcerative colitis (UC)-associated colorectal neoplasia (UCAN) in patients with UC and primary sclerosing cholangitis (PSC) has not been studied well in Japan. This retrospective study examined the clinicopathological features and prognosis of UCAN in patients with PSC-UC. Methods: A total of 808 patients with UCAN were enrolled from 1983 to 2020 and categorized into PSC (PSC-UCAN, n = 26) and no PSC (UCAN-alone, n = 782) groups. Clinicopathological features were compared between the 2 groups, and the 10-year overall survival (OS) and cancer-specific survival (CSS) were analyzed. Results: The PSC-UCAN group had a shorter UC duration before UCAN diagnosis (12.8 years vs. 16.9 years, P= 0.044), were younger at UCAN diagnosis (47.8 years vs. 53.3 years, P= 0.046), and developed UCAN more frequently in the right-sided colon (34.6% vs. 15.9%, P= 0.028) than the UCAN-alone group. The PSC-UCAN group showed a trend toward a lower proportion of high-grade dysplasia (19.2% vs. 30.7%) and a higher proportion of early-stage cancers (53.9% vs. 31.2%). The 10-year OS (64.6% vs. 79.3%, P=0.080) and CSS (80.8% vs. 83.9%, P=0.60) were comparable. Conclusions: Patients with PSC-UCAN showed earlier and younger development of UCAN than patients with only UCAN, with a high prevalence in the right-sided colon. Early-stage cancer was more frequently observed in the PSC-UCAN group, despite the shorter duration of UC. Patients with PSC-UC probably benefit from early initiation of surveillance colonoscopy.


  • Open Access

    Diagnostic Utility of Endoscopic Features and Endoscopic Ultrasonography for Ulcerative Colitis-Associated Neoplasia: A Retrospective Study on the Role of Endoscopic Submucosal Dissection as a Total Biopsy

    by Saki Yoshida, Yoriaki Komeda, Masashi Kono, Kohei Handa, Tomoyuki Nagai, Satoru Hagiwara, Shunsuke Omoto, Mamoru Takenaka, Hiroshi Kashida, George Tribonias, et al.

    Background/Objectives: Ulcerative colitis (UC)-associated neoplasia (UCAN) often presents as flat lesions with indistinct margins, and biopsy sensitivity is limited. Therefore, we evaluated endoscopic criteria to distinguish UCAN from sporadic neoplasia, assessing the accuracy of endoscopic ultrasonography (EUS) for invasion depth and the role of endoscopic submucosal dissection (ESD) as a “total biopsy.” Methods: We reviewed 212 endoscopically treated neoplastic lesions in UC-affected mucosa (April 2016–January 2025). We compared preoperative diagnoses using macroscopic type, pit pattern, and the Japan Narrow-Band Imaging Expert Team classification with final histology. We compared depth estimates with pathology in 10 UCAN-suspected lesions undergoing EUS. Lesions < 2 cm underwent conventional endoscopic resection, whereas those ≥ 2 cm underwent ESD. Results: No UCAN was found in 189 lesions < 2 cm. Among 23 ESD lesions, 8 suspected sporadic lesions were non-UCAN. Of 15 UCAN-suspected lesions, 8 were UCAN, 6 sporadic, and 1 inflammatory. For positive T1b or deeper invasion, the sensitivity, specificity, positive and negative predictive values, and overall accuracy of EUS were 50.0%, 100%, 100%, 88.9%, and 90.0%, respectively. EUS depth assessment agreed with pathology in 9/10 cases; nine lesions were T1a or shallower, and one was T1b. Third-layer thickening occurred in two lesions—both UCAN—including the T1b cancer. In ESD cases, redness and a VI pit pattern were independent predictors of UCAN. Conclusions: EUS-based depth assessment is useful for determining optimal treatment strategies. Beyond therapy, ESD enables comprehensive histologic assessment of the entire lesion, functioning as a total biopsy to guide management while preserving bowel function.

  • Open Access

    Robot-assisted vs. laparoscopic rectal cancer resection: a narrative review of oncological outcomes, functional results, and future perspectives

    by Kazuki Ueda, Masayoshi Iwamoto, Yoshinori Yane, Yusuke Makutani, Yasumasa Yoshioka, Koji Daito, Masahiro Haeno, Issei Umeda, Tadao Tokoro, Michel Gagner, et al.

    Robot-assisted rectal resection has increasingly gained acceptance as a minimally invasive surgical approach for rectal cancer, primarily due to its enhanced precision, dexterity, and superior visualization compared to traditional laparoscopic surgery. Accumulating evidence from randomized controlled trials, systematic reviews, and large-scale national registry analyses underscores its feasibility and safety, particularly in technically demanding scenarios such as male patients, obese individuals, and those with low rectal tumors. Robotic surgery demonstrates favorable short-term outcomes, including significantly lower conversion rates, reduced intraoperative blood loss, and accelerated postoperative recovery. Nonetheless, results regarding operative duration, postoperative complications, and cost-effectiveness remain heterogeneous. Additionally, robotic techniques may facilitate improved functional preservation, especially concerning urinary and sexual functions, attributed to superior visualization and precise nerve-sparing capabilities; however, these benefits require further rigorous validation. Continued advancements in robotic technology and growing surgical proficiency necessitate future large-scale, multicenter trials to definitively establish the long-term oncological and functional advantages. Emerging robotic platforms and technological innovations hold promise for reducing costs and enhancing accessibility. This narrative review critically examines current evidence, outlining the clinical benefits, inherent limitations, and prospective advancements in robotic-assisted surgery for rectal cancer.


  • Open Access

    Visualization of lymphatic flow in laparoscopic colon cancer surgery using indocyanine green fluorescence imaging

    by Hokuto Ushijima, Junichiro Kawamura, Kazuki Ueda, Yoshinori Yane, Yasumasa Yoshioka, Koji Daito, Tadao Tokoro, Jin-Ichi Hida, Kiyotaka Okuno

    Intraoperative visualization of lymphatic flow could guide surgeons performing laparoscopic colon cancer surgery on the extent of intestinal resection required. The purpose of this study was to investigate indocyanine green fluorescence imaging for intraoperative detection of lymphatic flow and nodes in such patients. All patients undergoing elective laparoscopic surgery for colorectal cancer from October 2016 to July 2017 were included in this study. Indocyanine green was injected submucosally around the tumors via a colonoscope and lymphatic flow assessed with a laparoscopic near-infrared camera system intraoperatively. Lymphatic flow was visualized perioperatively in 43 of 57 patients (75.4%). The rate of visualized lymphatic flow was significantly higher in patients with a lower clinical stage than in those with a higher clinical stage (p = 0.0103). Among the 14 patients in whom lymphatic flow was not visualized, 10 (71.4%) had cStage III or IV cancer. Our results indicate the potential role of intraoperative navigation in colon cancer surgery in early-stage colon cancers. This method allows the surgeon to clearly identify lymphatic flow during surgery and allows the determination and individualization of the lymph node dissection range.


  • Prognostic Factors for Patients With Advanced Colorectal Cancer and Symptomatic Brain Metastases

    by Tadao Tokoro, Kiyotaka Okuno, Jin-Chi Hida, Kazuki Ueda, Takehito Yoshifuji, Koji Daito, Fumiaki Sugiura


  • Open Access

    Analysis of the clinical factors associated with anal function after intersphincteric resection for very low rectal cancer

    by Tadao Tokoro, Kiyotaka Okuno, Jin-Ichi Hida, Kazuki Ueda, Tahehito Yoshifuji, Koji Daito, Masako Takemoto, Fumiaki Sugiura

    Intersphincteric resection (ISR) has been used to avoid permanent colostomy in very low rectal cancer patients. This study aimed to assess the surgical safety and oncologic and functional outcomes of ISR.